User since 11/29/2017
A phase IV randomised double-blind placebo-controlled dose titration trial with pramipexole Sifrol Mirapexin 0125-075 mgday per os to investigate the long-term efficacy safety and tolerability in patients with idiopathic moderate to severe...
The primary objective of the current study will be the evaluation of long-term efficacy of a 26-weeks treatment with pramipexole in patients with idiopathic moderate to severe Restless Legs Syndrome in comparison to placebo
The impact of liraglutide on glucose tolerance and the risk of type 2 diabetes in women with previous gestational diabetes mellitus
To investigate the effect of the glucagon-like peptide-1 receptor agonist liraglutide on patophysiological characteristics and the risk of type 2 diabetes mellitus in women with previous gestational diabetes mellitus GDM
Randomized Double blind Placebo-controlled Multicenter Phase II Study to Compare Four Dose Regimens of GLPG0634 Versus Placebo in Combination With Methotrexate Administered for 4 Weeks in the Treatment of Subjects With Active Rheumatoid Arthritis...
To evaluate the efficacy of GLPG0634 compared to placebo in terms of the proportion of subjects achieving an ACR20 response at Week 4
COMPARISON OF TWO KINETICS OF ADMINISTRATION OF BOLUS BY INSULIN PORTABLE PUMP ON THE GLUCOSE BLOOD STABILITY FOR INSULIN-DEPENDENT PATIENTS
COMPARISON OF DISPERSION OF THE CAPILLARY GLYCAEMIA INTO THE TWO GROUPS